Skip to main content
. Author manuscript; available in PMC: 2021 Oct 30.
Published in final edited form as: Leukemia. 2021 Mar 17;35(11):3188–3200. doi: 10.1038/s41375-021-01217-1

Figure 7: Cooperation of IL-10 suppression and immune checkpoint blockade.

Figure 7:

Created with BioRender.com. Model shows combining IL-10 suppression with anti-PD-L1 ICB enhances antitumor CD8+ T-cell activity by counteracting multiple methods of CLL immune suppression.